{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,21]],"date-time":"2026-10-21T16:50:14Z","timestamp":1792601414189,"version":"4.5.0"},"reference-count":24,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2023,11,4]],"date-time":"2023-11-04T00:00:00Z","timestamp":1699056000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"},{"start":{"date-parts":[[2023,11,4]],"date-time":"2023-11-04T00:00:00Z","timestamp":1699056000000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Sci Rep"],"abstract":"<jats:title>Abstract<\/jats:title><jats:p>We compared the predictive ability of the International Prognostic Index (IPI), a frequently used prognostic model for peripheral T-cell lymphoma (PTCL), with that of a type-specific prognostic model, the Prognostic Index for PTCL-U (PIT). We retrospectively analyzed 113 patients diagnosed with PTCL. The median age was 67 years (range, 16\u201388 years), 75 patients (66%) were male, and the most common disease type was PTCL, not otherwise specified (69%). With a median follow-up of 6.8 years (interquartile range, 2.7\u20139.9 years), 5-year survival rates for the four groups in IPI were 85%, 62%, 49%, and 13%, respectively. Similarly, 5-year survival rates for the four groups in PIT were 83%, 64%, 49%, and 19%, respectively. The area under the receiving operating characteristic curve for predicting mortality from PIT (0.725) was not significantly different from that from the IPI (0.685, <jats:italic>P<\/jats:italic>\u2009=\u20090.134). Multivariable analysis showed that performance status\u2009\u2265\u20092 (<jats:italic>P<\/jats:italic>\u2009&lt;\u20090.0001) and extranodal lesions\u2009\u2265\u20092 (<jats:italic>P<\/jats:italic>\u2009=\u20090.029) were significantly associated with lower overall survival. The present study found no significant difference in prognostic ability between the IPI and PIT for PTCL, and both models appear useful as predictive models.<\/jats:p>","DOI":"10.1038\/s41598-023-46501-5","type":"journal-article","created":{"date-parts":[[2023,11,4]],"date-time":"2023-11-04T11:02:27Z","timestamp":1699095747000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":5,"title":["Comparison of the prognostic impact of IPI and PIT in peripheral T-cell lymphoma in real-world practice with a large elderly population"],"prefix":"10.1038","volume":"13","author":[{"given":"Nobuhiko","family":"Nakamura","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Nobuhiro","family":"Kanemura","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Takuro","family":"Matsumoto","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hiroshi","family":"Nakamura","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yoshikazu","family":"Ikoma","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yuhei","family":"Shibata","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Junnichi","family":"Kitagawa","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Senji","family":"Kasahara","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Toshiki","family":"Yamada","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Michio","family":"Sawada","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yuto","family":"Kaneda","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kenji","family":"Fukuno","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Eri","family":"Takada","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hideko","family":"Goto","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Shin","family":"Lee","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kei","family":"Fujita","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Tetsuji","family":"Morishita","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Takeshi","family":"Hara","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hisashi","family":"Tsurumi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Masahito","family":"Shimizu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2023,11,4]]},"reference":[{"key":"46501_CR1","doi-asserted-by":"publisher","first-page":"706","DOI":"10.1002\/ajh.24791","volume":"92","author":"JO Armitage","year":"2017","unstructured":"Armitage, J. O. The aggressive peripheral T-cell lymphomas: 2017. Am. J. Hematol. 92, 706\u2013715 (2017).","journal-title":"Am. J. Hematol."},{"key":"46501_CR2","doi-asserted-by":"publisher","first-page":"227","DOI":"10.1007\/s12185-014-1520-3","volume":"99","author":"S Park","year":"2014","unstructured":"Park, S. & Ko, Y. H. Peripheral T cell lymphoma in Asia. Int. J. Hematol. 99, 227\u2013239 (2014).","journal-title":"Int. J. Hematol."},{"key":"46501_CR3","doi-asserted-by":"publisher","DOI":"10.3389\/fonc.2021.797028","volume":"11","author":"T-Y Kim","year":"2021","unstructured":"Kim, T.-Y. et al. Impact of Epstein-Barr virus on peripheral T-cell lymphoma not otherwise specified and angioimmunoblastic T-cell lymphoma. Front. Oncol. 11, 797028 (2021).","journal-title":"Front. Oncol."},{"key":"46501_CR4","doi-asserted-by":"publisher","first-page":"44","DOI":"10.1007\/s11912-020-00902-1","volume":"22","author":"PB Allen","year":"2020","unstructured":"Allen, P. B. & Pro, B. Therapy of peripheral T cell lymphoma: Focus on nodal subtypes. Curr. Oncol. Rep. 22, 44 (2020).","journal-title":"Curr. Oncol. Rep."},{"key":"46501_CR5","doi-asserted-by":"publisher","first-page":"4124","DOI":"10.1200\/JCO.2008.16.4558","volume":"26","author":"J Vose","year":"2008","unstructured":"Vose, J., Armitage, J., Weisenburger, D., International T-Cell Lymphoma Project. International peripheral T-cell and natural killer\/T-cell lymphoma study: pathology findings and clinical outcomes. J. Clin. Oncol. 26, 4124\u20134130 (2008).","journal-title":"J. Clin. Oncol."},{"key":"46501_CR6","doi-asserted-by":"publisher","first-page":"987","DOI":"10.1056\/NEJM199309303291402","volume":"329","author":"International Non-Hodgkin\u2019s Lymphoma Prognostic Factors Project","year":"1993","unstructured":"International Non-Hodgkin\u2019s Lymphoma Prognostic Factors Project. A predictive model for aggressive non-Hodgkin\u2019s lymphoma. N. Engl. J. Med. 329, 987\u2013994 (1993).","journal-title":"N. Engl. J. Med."},{"key":"46501_CR7","doi-asserted-by":"publisher","first-page":"2296","DOI":"10.1200\/JCO.1997.15.6.2296","volume":"15","author":"SM Ansell","year":"1997","unstructured":"Ansell, S. M. et al. Predictive capacity of the International Prognostic Factor Index in patients with peripheral T-cell lymphoma. J. Clin. Oncol. 15, 2296\u20132301 (1997).","journal-title":"J. Clin. Oncol."},{"key":"46501_CR8","first-page":"76","volume":"92","author":"C Gisselbrecht","year":"1998","unstructured":"Gisselbrecht, C. et al. Prognostic significance of T-cell phenotype in aggressive non-Hodgkin\u2019s lymphomas. Groupe d\u2019Etudes des Lymphomes de l\u2019Adulte (GELA). Blood 92, 76\u201382 (1998).","journal-title":"Blood"},{"key":"46501_CR9","doi-asserted-by":"publisher","first-page":"2474","DOI":"10.1182\/blood-2003-09-3080","volume":"103","author":"A Gallamini","year":"2004","unstructured":"Gallamini, A. et al. Peripheral T-cell lymphoma unspecified (PTCL-U): A new prognostic model from a retrospective multicentric clinical study. Blood 103, 2474\u20132479 (2004).","journal-title":"Blood"},{"key":"46501_CR10","doi-asserted-by":"publisher","first-page":"397","DOI":"10.1093\/annonc\/mdq359","volume":"22","author":"G Guti\u00e9rrez-Garc\u00eda","year":"2011","unstructured":"Guti\u00e9rrez-Garc\u00eda, G. et al. Comparison of four prognostic scores in peripheral T-cell lymphoma. Ann. Oncol. 22, 397\u2013404 (2011).","journal-title":"Ann. Oncol."},{"key":"46501_CR11","doi-asserted-by":"publisher","first-page":"3402","DOI":"10.1182\/blood-2010-09-310342","volume":"117","author":"DD Weisenburger","year":"2011","unstructured":"Weisenburger, D. D. et al. Peripheral T-cell lymphoma, not otherwise specified: a report of 340 cases from the International Peripheral T-cell Lymphoma Project. Blood 117, 3402\u20133408 (2011).","journal-title":"Blood"},{"key":"46501_CR12","doi-asserted-by":"publisher","first-page":"239","DOI":"10.1007\/s00277-014-2188-8","volume":"94","author":"P Xu","year":"2015","unstructured":"Xu, P. et al. Analysis of prognostic factors and comparison of prognostic scores in peripheral T cell lymphoma, not otherwise specified: A single-institution study of 105 Chinese patients. Ann. Hematol. 94, 239\u2013247 (2015).","journal-title":"Ann. Hematol."},{"key":"46501_CR13","doi-asserted-by":"publisher","first-page":"e24","DOI":"10.1111\/bjh.15859","volume":"186","author":"F Ellin","year":"2019","unstructured":"Ellin, F. et al. Comparison of the NCCN-IPI, the IPI and PIT scores as prognostic tools in peripheral T-cell lymphomas. Br. J. Haematol. 186, e24\u2013e27 (2019).","journal-title":"Br. J. Haematol."},{"key":"46501_CR14","doi-asserted-by":"publisher","first-page":"819","DOI":"10.1080\/10428194.2020.1845336","volume":"62","author":"S Yamasaki","year":"2021","unstructured":"Yamasaki, S. et al. Comparison of prognostic scores in transplant-ineligible patients with peripheral T-cell lymphoma not otherwise specified and angioimmunoblastic T-cell lymphoma: A retrospective study from the national hospital organization in Japan. Leuk. Lymphoma 62, 819\u2013827 (2021).","journal-title":"Leuk. Lymphoma"},{"key":"46501_CR15","doi-asserted-by":"publisher","first-page":"425","DOI":"10.1093\/geront\/gnr067","volume":"51","author":"N Muramatsu","year":"2011","unstructured":"Muramatsu, N. & Akiyama, H. Japan: Super-aging society preparing for the future. Gerontologist 51, 425\u2013432 (2011).","journal-title":"Gerontologist"},{"key":"46501_CR16","first-page":"7550","volume":"40","author":"R Stuver","year":"2022","unstructured":"Stuver, R., Mazloom, A., Ganesan, N., Horwitz, S. M. & Moskowitz, A. J. Impact of bone marrow involvement in patients with peripheral T-cell lymphoma undergoing autologous stem cell transplant. J. Clin. Orthod. 40, 7550\u20137550 (2022).","journal-title":"J. Clin. Orthod."},{"key":"46501_CR17","doi-asserted-by":"publisher","first-page":"229","DOI":"10.1016\/S0140-6736(18)32984-2","volume":"393","author":"S Horwitz","year":"2019","unstructured":"Horwitz, S. et al. Brentuximab vedotin with chemotherapy for CD30-positive peripheral T-cell lymphoma (ECHELON-2): A global, double-blind, randomised, phase 3 trial. Lancet 393, 229\u2013240 (2019).","journal-title":"Lancet"},{"key":"46501_CR18","doi-asserted-by":"publisher","first-page":"811","DOI":"10.1182\/blood.V106.11.811.811","volume":"106","author":"JM Vose","year":"2005","unstructured":"Vose, J. M. International Peripheral T-Cell Lymphoma (PTCL) Clinical and Pathologic Review Project: Poor outcome by prognostic indices and lack of efficacy with anthracyclines. Blood 106, 811\u2013811 (2005).","journal-title":"Blood"},{"key":"46501_CR19","doi-asserted-by":"publisher","first-page":"2472","DOI":"10.1200\/JCO.2005.03.6327","volume":"24","author":"P Went","year":"2006","unstructured":"Went, P. et al. Marker expression in peripheral T-cell lymphoma: A proposed clinical-pathologic prognostic score. J. Clin. Oncol. 24, 2472\u20132479 (2006).","journal-title":"J. Clin. Oncol."},{"key":"46501_CR20","doi-asserted-by":"publisher","first-page":"2375","DOI":"10.1182\/blood-2016-01-643569","volume":"127","author":"SH Swerdlow","year":"2016","unstructured":"Swerdlow, S. H. et al. The 2016 revision of the World Health Organization classification of lymphoid neoplasms. Blood 127, 2375\u20132390 (2016).","journal-title":"Blood"},{"key":"46501_CR21","doi-asserted-by":"publisher","first-page":"837","DOI":"10.1182\/blood-2013-09-524108","volume":"123","author":"Z Zhou","year":"2014","unstructured":"Zhou, Z. et al. An enhanced International Prognostic Index (NCCN-IPI) for patients with diffuse large B-cell lymphoma treated in the rituximab era. Blood 123, 837\u2013842 (2014).","journal-title":"Blood"},{"key":"46501_CR22","doi-asserted-by":"publisher","first-page":"132","DOI":"10.1111\/j.1365-2753.2005.00598.x","volume":"12","author":"A Linden","year":"2006","unstructured":"Linden, A. Measuring diagnostic and predictive accuracy in disease management: An introduction to receiver operating characteristic (ROC) analysis. J. Eval. Clin. Pract. 12, 132\u2013139 (2006).","journal-title":"J. Eval. Clin. Pract."},{"key":"46501_CR23","doi-asserted-by":"publisher","first-page":"565","DOI":"10.1177\/0272989X06295361","volume":"26","author":"AJ Vickers","year":"2006","unstructured":"Vickers, A. J. & Elkin, E. B. Decision curve analysis: A novel method for evaluating prediction models. Med. Decis. Mak. 26, 565\u2013574 (2006).","journal-title":"Med. Decis. Mak."},{"key":"46501_CR24","doi-asserted-by":"publisher","first-page":"452","DOI":"10.1038\/bmt.2012.244","volume":"48","author":"Y Kanda","year":"2013","unstructured":"Kanda, Y. Investigation of the freely available easy-to-use software \u201cEZR\u201d for medical statistics. Bone Marrow Transplant. 48, 452\u2013458 (2013).","journal-title":"Bone Marrow Transplant."}],"container-title":["Scientific Reports"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.nature.com\/articles\/s41598-023-46501-5.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s41598-023-46501-5","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s41598-023-46501-5.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2023,11,4]],"date-time":"2023-11-04T11:04:45Z","timestamp":1699095885000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.nature.com\/articles\/s41598-023-46501-5"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2023,11,4]]},"references-count":24,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2023,12]]}},"alternative-id":["46501"],"URL":"https:\/\/doi.org\/10.1038\/s41598-023-46501-5","relation":{},"ISSN":["2045-2322"],"issn-type":[{"value":"2045-2322","type":"electronic"}],"subject":[],"published":{"date-parts":[[2023,11,4]]},"assertion":[{"value":"10 February 2023","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"1 November 2023","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"4 November 2023","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"The authors declare no competing interests.","order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}],"article-number":"19060"}}